This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Apr;6(4):e361-e362.

doi: 10.1016/S2214-109X(18)30068-8. Epub 2018 Feb 19.

Rethinking tuberculosis control by targeting previously treated individuals

Ellen Brooks-Pollock¹, Karen R Jacobson²

Affiliations

Affiliations

¹ Bristol Veterinary School, University of Bristol, BS40 5DU, UK; Population Health Sciences, Bristol Medical School, University of Bristol, UK. Electronic address: Ellen.Brooks-Pollock@bristol.ac.uk.
² Section of Infectious Diseases, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA.

PMID: 29472017
DOI: 10.1016/S2214-109X(18)30068-8

Free article

Comment

Rethinking tuberculosis control by targeting previously treated individuals

Ellen Brooks-Pollock et al. Lancet Glob Health. 2018 Apr.

Free article

. 2018 Apr;6(4):e361-e362.

doi: 10.1016/S2214-109X(18)30068-8. Epub 2018 Feb 19.

Authors

Ellen Brooks-Pollock¹, Karen R Jacobson²

Affiliations

¹ Bristol Veterinary School, University of Bristol, BS40 5DU, UK; Population Health Sciences, Bristol Medical School, University of Bristol, UK. Electronic address: Ellen.Brooks-Pollock@bristol.ac.uk.
² Section of Infectious Diseases, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA.

PMID: 29472017
DOI: 10.1016/S2214-109X(18)30068-8

No abstract available

PubMed Disclaimer

Comment on

Tuberculosis control interventions targeted to previously treated people in a high-incidence setting: a modelling study.
Marx FM, Yaesoubi R, Menzies NA, Salomon JA, Bilinski A, Beyers N, Cohen T. Marx FM, et al. Lancet Glob Health. 2018 Apr;6(4):e426-e435. doi: 10.1016/S2214-109X(18)30022-6. Epub 2018 Feb 19. Lancet Glob Health. 2018. PMID: 29472018 Free PMC article.

Similar articles

Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y, Zhou S, Deng Q, Li X, Meng J, Guan Y, Li C, Xiao C. Liu Y, et al. Tuberculosis (Edinb). 2016 Mar;97:38-46. doi: 10.1016/j.tube.2015.12.003. Epub 2016 Jan 6. Tuberculosis (Edinb). 2016. PMID: 26980494
[Surgical therapy of patients with pulmonary tuberculosis caused by Mycobacterium tuberculosis resistant to antitubercular agents].
KALANDADZE ZF, KOPEIKO IP, SEMENKIN PA. KALANDADZE ZF, et al. Probl Tuberk. 1962;40(6):48-51. Probl Tuberk. 1962. PMID: 13961884 Russian. No abstract available.
[COMPARISON OF THE SENSITIVITY OF MYCOBACTERIUM TUBERCULOSIS BEFORE OPERATION AND MYCOBACTERIA ISOLATED FROM RESECTED MATERIAL].
SHNAIDR V, FISHER F, KHODOUNSKA V, KRAKORA P, SPOUSTRA I. SHNAIDR V, et al. Probl Tuberk. 1964;42:64-7. Probl Tuberk. 1964. PMID: 14255438 Russian. No abstract available.
Multi-Target Antitubercular Drugs.
de Oliveira Viana J, Ishiki HM, Scotti MT, Scotti L. de Oliveira Viana J, et al. Curr Top Med Chem. 2018;18(9):750-758. doi: 10.2174/1568026618666180528124414. Curr Top Med Chem. 2018. PMID: 29807515 Review.
[PRIMARY RESISTANCE OF M. TUBERCULOSIS AGAINST ANTITUBERCULAR AGENTS].
TRNKA L, URBANCIK R. TRNKA L, et al. Cas Lek Cesk. 1963 Jul 12;102:793-801. Cas Lek Cesk. 1963. PMID: 14074220 Review. Czech. No abstract available.

See all similar articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information